RxDoctor Payments Data

Robert Wilson, MD

Otolaryngology · Danville, KYNPI 1861646374

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.3% of the total across 125 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by Stryker at 36.6% of the total. 2025 is the largest year on record at $1,666, 3.1 times the $537 reported in 2019.

$5,703in general payments, 2019–2025

Across 125 payments — averaging $45.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$2K
  • Biotissue Holdings Inc.$1K
  • Regeneron Healthcare Solutions, Inc.$763
  • Sanofi$360
  • GSK$330
  • Intersect ENT, Inc.$189
  • plus $611 from 12 others

What the payments were for

  • Food & beverage$5,54997%
  • Education$1543%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,703 in reported general payments places this provider in the 85th percentile of 137 otolaryngology providers in Kentucky.

See all otolaryngology providers in Kentucky

Medicare billing

Part B allowed, 2024
$68,362
Medicare patients
242
Services billed
652

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ofloxacin91$3,134
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth38$2,615
Ipratropium Bromide38$1,458
Azelastine Hcl59$1,080
Doxycycline Monohydrate61$762
Montelukast Sodium70$448
Fluticasone Propionate52$443
Nystatin-TriamcinoloneNystatin/Triamcinolone Acet40$442
Omeprazole41$301
Prednisone176$223
Mupirocin40$203
Clindamycin Hcl24$202
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav21$169
Ciprofloxacin Hcl12$150
Pantoprazole Sodium14$148

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Danville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →